Therefore, a model system allowing study of the enzymatic and functional properties of wild-type and pathogenic TPI variants without additional side effects due to differing environment and genetic background is required to gaining insights into the molecular mechanism implicated in TPI deficiency. This evidence concerns the gene TPI1 and hyperinsulinemic hypoglycemia, familial, 4.